Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, 88, Olympic-ro 43-Gil, Songpa-Gu, Seoul, 05505, South Korea.
Metab Brain Dis. 2019 Oct;34(5):1335-1340. doi: 10.1007/s11011-019-00441-0. Epub 2019 May 25.
Lesch-Nyhan syndrome (LNS) is an X-linked recessive disorder caused by mutations in the HPRT1 gene. The clinical features and mutation spectrum of 26 Korean LNS patients from 23 unrelated families were retrospectively reviewed. The HPRT1 gene was analyzed by direct sequencing of genomic DNA. The median age at diagnosis was 2.3 years (range, 4 months-22.6 years) and the initial presenting features included developmental delay, orange colored urine, and self-injurious behaviors. Most patients were wheelchair-bound and suffered from urinary complications and neurologic problems such as self-mutilation and developmental delay. Twenty different mutations in HPRT1 were identified among 23 independent pedigrees, including six novel mutations. The most common mutation type was truncating mutations including nonsense and frameshift mutations (45%). Large deletions in the HPRT1 gene were identified in exon 1, exons 5-6, exons 1-9, and at chr X:134,459,540-134,467,241 (7702 bp) including the 5'-untranslated region, exon 1, and a portion of intron 1. In conclusion, this study describes the phenotypic spectrum of LNS and has identified 20 mutations from 23 Korean families, including six novel mutations in Korean patients with LNS.
莱施-尼汉综合征(Lesch-Nyhan syndrome,LNS)是一种 X 连锁隐性遗传病,由 HPRT1 基因突变引起。本研究回顾性分析了 23 个不相关家系的 26 例韩国 LNS 患者的临床特征和突变谱。通过对基因组 DNA 进行直接测序分析 HPRT1 基因。诊断时的中位年龄为 2.3 岁(范围为 4 个月-22.6 岁),初始表现包括发育迟缓、橙色尿液和自残行为。大多数患者需要坐轮椅,伴有尿并发症和神经问题,如自残和发育迟缓。在 23 个独立家系中发现了 20 种不同的 HPRT1 突变,包括 6 种新突变。最常见的突变类型是截断突变,包括无义突变和移码突变(45%)。在 HPRT1 基因中发现了大片段缺失,包括外显子 1、外显子 5-6、外显子 1-9 和 chr X:134,459,540-134,467,241(7702 bp),包括 5'-非翻译区、外显子 1 和部分内含子 1。总之,本研究描述了 LNS 的表型谱,并从 23 个韩国家系中鉴定出 20 种突变,包括 6 种韩国 LNS 患者的新突变。